MDxHealth SA Sustainability Reports
MDxHealth S.A. is a commercial-stage precision diagnostics company that provides non-invasive, clinically actionable molecular urologic solutions. Its genomic and epigenetic testing solutions assist physicians with the diagnosis, prognosis, and treatment selection of urologic cancers and diseases.
Sector: Manufacturing
Country: Belgium
Exchange: Nasdaq
ISIN: BE0974461940
9 reports from 2013 to 2025